Literature DB >> 15306570

Is gastric cancer preventable?

P Correa1.   

Abstract

Gastric cancer is a major health burden worldwide and prevention is the most promising strategy to control the disease. The available scientific evidence indicates that curing Helicobacter pylori infection results in a modest retardation of the precancerous process but does not prevent all cancers. Individuals at the highest risk should be cured of their infection and monitored endoscopically to detect dysplasia and "early" cancer, amenable to successful treatment.

Entities:  

Mesh：

Year:  2004        PMID： 15306570      PMCID： PMC1774190          DOI： 10.1136/gut.2004.039834

Source DB:  PubMed          Journal:  Gut        ISSN： 0017-5749            Impact factor:   23.059


  16 in total

Review 1.  Cancer burden in the year 2000. The global picture.

Authors:  D M Parkin; F I Bray; S S Devesa
Journal:  Eur J Cancer       Date:  2001-10       Impact factor: 9.162

2.  Interleukin-1 polymorphisms associated with increased risk of gastric cancer.

Authors:  E M El-Omar; M Carrington; W H Chow; K E McColl; J H Bream; H A Young; J Herrera; J Lissowska; C C Yuan; N Rothman; G Lanyon; M Martin; J F Fraumeni; C S Rabkin
Journal:  Nature       Date:  2000-03-23       Impact factor: 49.962

3.  Chemoprevention of gastric dysplasia: randomized trial of antioxidant supplements and anti-helicobacter pylori therapy.

Authors:  P Correa; E T Fontham; J C Bravo; L E Bravo; B Ruiz; G Zarama; J L Realpe; G T Malcom; D Li; W D Johnson; R Mera
Journal:  J Natl Cancer Inst       Date:  2000-12-06       Impact factor: 13.506

4.  Helicobacter pylori infection and the development of gastric cancer.

Authors:  N Uemura; S Okamoto; S Yamamoto; N Matsumura; S Yamaguchi; M Yamakido; K Taniyama; N Sasaki; R J Schlemper
Journal:  N Engl J Med       Date:  2001-09-13       Impact factor: 91.245

5.  A five-year follow-up study on the pathological changes of gastric mucosa after H. pylori eradication.

Authors:  Liya Zhou; Joseph J Y Sung; Sanren Lin; Zhu Jin; Shigang Ding; Xuebiao Huang; Zhiwei Xia; Huilan Guo; Jianjun Liu; William Chao
Journal:  Chin Med J (Engl)       Date:  2003-01       Impact factor: 2.628

6.  Morphometric evaluation of gastric antral atrophy: improvement after cure of Helicobacter pylori infection.

Authors:  B Ruiz; J Garay; P Correa; E T Fontham; J C Bravo; L E Bravo; J L Realpe; R Mera
Journal:  Am J Gastroenterol       Date:  2001-12       Impact factor: 10.864

7.  Progression of chronic atrophic gastritis associated with Helicobacter pylori infection increases risk of gastric cancer.

Authors:  Hiroshi Ohata; Shintaro Kitauchi; Noriko Yoshimura; Kouichi Mugitani; Masataka Iwane; Hideya Nakamura; Akiyoshi Yoshikawa; Kimihiko Yanaoka; Kenji Arii; Hideyuki Tamai; Yasuhito Shimizu; Tatsuya Takeshita; Osamu Mohara; Masao Ichinose
Journal:  Int J Cancer       Date:  2004-03       Impact factor: 7.396

8.  Helicobacter pylori eradication to prevent gastric cancer in a high-risk region of China: a randomized controlled trial.

Authors:  Benjamin Chun-Yu Wong; Shiu Kum Lam; Wai Man Wong; Jian Shun Chen; Ting Ting Zheng; Rui E Feng; Kam Chuen Lai; Wayne Hsing Cheng Hu; Siu Tsan Yuen; Suet Yi Leung; Daniel Yee Tak Fong; Joanna Ho; Chi Kong Ching; Jun Shi Chen
Journal:  JAMA       Date:  2004-01-14       Impact factor: 56.272

9.  Helicobacter pylori and interleukin 1 genotyping: an opportunity to identify high-risk individuals for gastric carcinoma.

Authors:  Céu Figueiredo; José Carlos Machado; Paul Pharoah; Raquel Seruca; Sónia Sousa; Ralph Carvalho; Ana Filipa Capelinha; Wim Quint; Carlos Caldas; Leen-Jan van Doorn; Fátima Carneiro; Manuel Sobrinho-Simões
Journal:  J Natl Cancer Inst       Date:  2002-11-20       Impact factor: 13.506

10.  Helicobacter pylori eradication and gastric preneoplastic conditions: a randomized, double-blind, placebo-controlled trial.

Authors:  Catherine Ley; Alejandro Mohar; Jeannette Guarner; Roberto Herrera-Goepfert; Luz Sanchez Figueroa; David Halperin; Iain Johnstone; Julie Parsonnet
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2004-01       Impact factor: 4.254
View more
  28 in total

1.  Can endoscopic atrophy predict histological atrophy? Historical study in United Kingdom and Japan.

Authors:  Shin Kono; Takuji Gotoda; Shigeaki Yoshida; Ichiro Oda; Hitoshi Kondo; Luigi Gatta; Greg Naylor; Michael Dixon; Fuminori Moriyasu; Anthony Axon
Journal:  World J Gastroenterol       Date:  2015-12-14       Impact factor: 5.742

2.  SIRT1 counteracted the activation of STAT3 and NF-κB to repress the gastric cancer growth.

Authors:  Juanjuan Lu; Liping Zhang; Xiang Chen; Qiming Lu; Yuxia Yang; Jingping Liu; Xin Ma
Journal:  Int J Clin Exp Med       Date:  2014-12-15

3.  Evaluation of the excluded stomach by double-balloon endoscopy after laparoscopic Roux-en-Y gastric bypass.

Authors:  Nobumi Tagaya; Kazunori Kasama; Susumu Inamine; Osamu Zaha; Kazunari Kanke; Youichirou Fujii; Eiji Kanehira; Hideyuki Hiraishi; Keiichi Kubota
Journal:  Obes Surg       Date:  2007-09       Impact factor: 4.129

4.  Omission of breakfast and risk of gastric cancer in Mexico.

Authors:  Monserrat Verdalet-Olmedo; Clara Luz Sampieri; Jaime Morales-Romero; Hilda Montero-L de Guevara; Alvaro Manuel Machorro-Castaño; Kenneth León-Córdoba
Journal:  World J Gastrointest Oncol       Date:  2012-11-15

Review 5.  Effect of Helicobacter pylori on gastric epithelial cells.

Authors:  Shatha Alzahrani; Taslima T Lina; Jazmin Gonzalez; Irina V Pinchuk; Ellen J Beswick; Victor E Reyes
Journal:  World J Gastroenterol       Date:  2014-09-28       Impact factor: 5.742

Review 6.  Gastric cancer research in Mexico: a public health priority.

Authors:  Clara Luz Sampieri; Mauricio Mora
Journal:  World J Gastroenterol       Date:  2014-04-28       Impact factor: 5.742

Review 7.  New advances in targeted gastric cancer treatment.

Authors:  Daniela Cornelia Lazăr; Sorina Tăban; Marioara Cornianu; Alexandra Faur; Adrian Goldiş
Journal:  World J Gastroenterol       Date:  2016-08-14       Impact factor: 5.742

8.  Racial/Ethnic Differences in Cancers Attributable to Preventable Infectious Agents in Texas, 2015.

Authors:  Franciska J Gudenkauf; Aaron P Thrift
Journal:  Public Health Rep       Date:  2020-10-20       Impact factor: 2.792

9.  Regulation of the Helicobacter pylori cellular receptor decay-accelerating factor.

Authors:  Daniel P O'Brien; Judith Romero-Gallo; Barbara G Schneider; Rupesh Chaturvedi; Alberto Delgado; Elizabeth J Harris; Uma Krishna; Seth R Ogden; Dawn A Israel; Keith T Wilson; Richard M Peek
Journal:  J Biol Chem       Date:  2008-06-25       Impact factor: 5.157

10.  Molecular epidemiology of gastric cancer: current status and future prospects.

Authors:  Zhibin Hu; Jaffer A Ajani; Qingyi Wei
Journal:  Gastrointest Cancer Res       Date:  2007-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.